Ohr Pharmaceutical announces proposed public offering of common stock and warrants
Ohr Pharmaceutical announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock and warrants to purchase common stock in a public offering. H.C. Wainwright is serving as exclusive placement agent for this offering. December 07, 2016